logo
GaldermaExpandsRestylanePortfolioinJapanWithLaunchofOBTHyaluronicAcidInjectablesRestylaneDefyneandRefyne
===2026/2/11 14:29:40===

Öhrlund Å. Differentiation of NASHA and OBT hyaluronic acid gels according to strength, flexibility, and associated clinical significance.J Drugs Dermatol.2014;23(1):1332-1336. doi: 10.36849/JDD.7648

Galderma. Data on file. MA-57232 [Updated]. 77 Million treated. 2025

Galderma. Data on file. MA-55607. Restylane®27 years data publications analysis. 2023

Fabi G, et al. The potential role of biostimulators/dermal fillers to address menopause-related skin conditions. Poster presented at IMCAS; January 29-31, 2026; Paris, France

Lorenc ZP, et al. Synergistic efficacy and safety of poly-L-lactic acid biostimulator and hyaluronic acid filler for facial fullness post weight loss due to glucagon-like peptide-1 receptor agonist medication. Presented at the ASDS 2025 Annual Meeting; November 13-16; Chicago, United States

Nikolis A, et al. The role of clinical examination in midface volume correction using hyalu
=*=*=*=*=*=
当前为第9/11页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页